The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

Investigators at Dana-Farber Cancer Institute are opening a new clinical trial to evaluate a novel type of immune cellular ...

Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...

Cordyceps militaris, also known as caterpillar fungus, zombifies ground-dwelling insect larvae. They feast on the critter ...

A clinical trial at Stanford Medicine has shown that CAR-T cell therapy, a cancer treatment, can effectively treat brain ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

As Sri Lanka's healthcare system struggles to get back on its feet following the election of a new president in September, ...

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

Researchers have identified a potential treatment for Sandhoff and Tay-Sachs diseases -- two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain and ...

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

The disorder is estimated to affect fewer than 1,000 people in the United States, according to data from the National ... to ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...